Data as of Aug 25, 2026 · Based on 40 AI responses from ChatGPT Search and Google AI Mode · See how Parse measures this
Your brand can be here too.
If by “take over” you mean replace a human PA operations team for most of the workflow—intake → determine whether auth is required → gather clinical documentation → submit → chase payer → respond to requests → track status → escalate exceptions—the market has a handful of credible AI-native contenders.
The important distinction is which side of the transaction you sit on: payer/health plan vs. provider/health system vs. pharma hub.
| Vendor | Best fit | What AI can take over | How close to “human team replacement”? |
|---|---|---|---|
| Cohere Health | Health plans / payers | Intake, clinical review, medical-necessity decisioning, policy application, approvals, some downstream UM | Very high for payer-side PA |
| Waystar | Providers / health systems | Determine auth requirement, assemble documentation, submit, track, work queues | High for administrative PA |
| Rhyme | Providers + payers | EHR-integrated PA submission, payer connectivity, workflow automation | High, particularly as infrastructure |
| Infinitus | Pharma hubs / access teams / providers | Phone calls to payers, benefits/auth follow-up, status checks, documentation workflows | High for phone-heavy operations |
| Neon Health | Pharma / patient access | Hub/access workflows and payer interactions | Potentially high, especially hub operations |
| Infinx | Provider RCM | PA workflow automation, documentation, status tracking and revenue-cycle work | Medium-high |
| Anterior | Payers / clinical operations | Clinical documentation extraction, medical-necessity assessment and review assistance | Medium-high, particularly clinical review |
| Elsai | Provider-side PA | Agentic PA workflow, evidence gathering, submission and follow-up | Emerging / high potential |
Cohere is probably the most interesting company if you're talking about a health plan replacing an internal utilization-management/PA operation rather than simply buying a better PA submission tool.
Its platform is explicitly designed for touchless prior authorization, with AI applying health-plan policies and clinical criteria. Cohere currently claims 85% of authorizations can be approved in real time, with the remaining cases going to clinicians. It also offers a delegated model in which Cohere provides the operational/clinical staff rather than merely software.
That last point is important: software + delegated clinical operations is much closer to “replace my PA department” than most AI vendors.
Waystar is attacking PA from the provider/revenue-cycle side. Its Authorization Manager uses automation to determine authorization requirements, submit requests and attach clinical documentation; industry reporting describes it as processing tens of millions of authorization transactions annually.
This is less “AI replaces nurses making clinical determinations” and more:
AI replaces the staff whose job is to figure out whether auth is needed, assemble the packet, submit it, monitor it and work the queue. That's potentially a huge portion of a provider organization's PA headcount.
Rhyme is particularly interesting because it sits at the EHR ↔ payer connectivity layer. Its partnership with Cohere was explicitly aimed at automating the end-to-end PA process: Rhyme handles EMR integration while Cohere handles the clinical authorization intelligence.
So I wouldn't necessarily view Rhyme as a standalone “AI ops replacement.” I'd view it as an important piece of an agentic PA stack.
Infinitus is interesting for a different reason: voice agents.
A surprising amount of PA work still consists of humans calling payers, navigating IVRs, checking status, obtaining information and documenting conversations. An AI voice agent can perform those interactions continuously and feed the results back into the PA workflow.
For organizations whose PA team spends a lot of its time on the phone rather than making clinical decisions, this can have unusually high labor-replacement potential.
Anterior is more focused on the clinical reasoning/document-review portion of authorization. This is the piece that traditional RPA can't easily automate: interpreting records, extracting relevant evidence and determining whether the documentation supports medical necessity.
It's therefore more complementary to the administrative automation vendors than a replacement for the entire workflow.
Elsai is one of the newer companies explicitly positioning itself around agentic prior authorization, rather than simply digitizing forms.
That distinction matters. The emerging architecture is essentially:
AI agent receives request → reads chart → determines requirements → retrieves evidence → fills payer workflow → submits → monitors → responds to requests → escalates only exceptions.
A 2026 industry comparison identifies Elsai alongside Cohere, Waystar, Rhyme, Navina and Infinitus as notable PA-AI players.
I would divide the market into three categories:
Look hardest at:
Look at:
Cohere itself describes Review Assist as surfacing the relevant clinical evidence for nurses inside their existing UM environment rather than removing the human reviewer altogether.
This is a somewhat different market. Infinitus and Neon Health are particularly relevant; industry analysis currently places them in the direct hub-automation category, while Cohere is principally a payer-side platform rather than a pharma-hub replacement.
I'd actually score vendors against six autonomous steps, rather than asking “does it have AI?”:
The vendor that can do all six is capable of replacing an operations team. A vendor that only automates #3 is basically a better PA clearinghouse.
My short list for an actual 2026 enterprise evaluation would be Cohere, Waystar, Rhyme, Infinitus, and Elsai, with the shortlist changing substantially depending on whether you're a payer, provider, or pharma company. The market is also increasingly converging on AI agents + payer connectivity + clinical intelligence, rather than one monolithic PA application.
If you tell me whether you're looking at this from a payer, health-system, specialty-pharmacy, or pharma-hub perspective, I can map the vendors much more precisely—including which ones can actually eliminate FTEs vs. merely augment them, approximate pricing/business models, and who has real production deployments.
This is less “AI replaces nurses making clinical determinations” and more:
AI replaces the staff whose job is to figure out whether auth is needed, assemble the packet, submit it, monitor it and work the queue. That's potentially a huge portion of a provider organization's PA headcount.
Rhyme is particularly interesting because it sits at the EHR ↔ payer connectivity layer. Its partnership with Cohere was explicitly aimed at automating the end-to-end PA process: Rhyme handles EMR integration while Cohere handles the clinical authorization intelligence.
So I wouldn't necessarily view Rhyme as a standalone “AI ops replacement.” I'd view it as an important piece of an agentic PA stack.
Infinitus is interesting for a different reason: voice agents.
A surprising amount of PA work still consists of humans calling payers, navigating IVRs, checking status, obtaining information and documenting conversations. An AI voice agent can perform those interactions continuously and feed the results back into the PA workflow.
For organizations whose PA team spends a lot of its time on the phone rather than making clinical decisions, this can have unusually high labor-replacement potential.
Anterior is more focused on the clinical reasoning/document-review portion of authorization. This is the piece that traditional RPA can't easily automate: interpreting records, extracting relevant evidence and determining whether the documentation supports medical necessity.
It's therefore more complementary to the administrative automation vendors than a replacement for the entire workflow.
Elsai is one of the newer companies explicitly positioning itself around agentic prior authorization, rather than simply digitizing forms.
That distinction matters. The emerging architecture is essentially:
AI agent receives request → reads chart → determines requirements → retrieves evidence → fills payer workflow → submits → monitors → responds to requests → escalates only exceptions.
A 2026 industry comparison identifies Elsai alongside Cohere, Waystar, Rhyme, Navina and Infinitus as notable PA-AI players.
I would divide the market into three categories:
Look hardest at:
The healthcare landscape has seen an emergence of AI-native and AI-powered platforms designed to reduce or completely take over the heavy lifting of prior authorization (PA) workflows from human operations teams. Rather than just acting as basic optical character recognition (OCR) or manual form-fillers, these modern services leverage Large Language Models (LLMs), intelligent document processing, and FHIR-based APIs to interpret complex clinical criteria, match them against payer medical policies, pre-fill documentation, and automate submissions.
Major AI-Driven Services & Platforms
How These Services Operate Under the Hood
Modern AI-native systems handle tasks that traditionally required an army of human intake coordinators or clinical nurses:
Note on Human Oversight: While these platforms drastically reduce the need for manual operations teams, fully autonomous "auto-approval" is usually restricted to routine or highly standardized cases. Complex or borderline clinical denials still often route to a streamlined human-in-the-loop queue where AI acts as a clinical review assistant.
Would you like to explore solutions tailored specifically for providers/health systems vs. payers/insurance plans , or focus on a particular EHR integration (like Epic or Cerner)?
Yes. A growing group of AI-native companies is specifically trying to replace much of the work currently performed by prior authorization specialists, rather than simply providing workflow software or electronic prior authorization (ePA) routing.
The market naturally breaks into two categories:
| Type | Buyer | Goal |
|---|---|---|
| Provider-side AI agents | Health systems, physician groups, MSOs, specialty clinics | Replace staff performing submissions, follow-ups, phone calls, and documentation |
| Payer-side AI platforms | Health plans, PBMs | Automate intake, clinical review, and utilization management |
These are the closest to replacing a human operations team.
| Company | What the AI does | Human work replaced |
|---|---|---|
| Honey Health | Detects PA requirements, gathers documentation, submits, monitors status, updates EHR | PA coordinators, follow-up specialists, portal work Honey Health |
| Mandolin | End-to-end specialty drug workflow including benefits investigation, PA, payer calls, revenue cycle | Infusion authorization teams, specialty pharmacy ops Mandolin |
| Ascertain | Prior auth, referrals, eligibility, appeals, fax ingestion | Administrative coordinators across revenue cycle Ascertain |
| GenHealth | Creates payer-specific packets, submits through multiple channels, polls status, routes exceptions | Manual submission and tracking teams GenHealth |
| Beija | Benefits investigation + PA inside existing EHR | Small practice back-office staff Beija |
| SamaCare | Specialty drug medical-benefit PA automation | Specialty practice authorization teams Honey Health |
| Silna Health | AI-first specialty and infusion PA | Specialty authorization staff Honey Health |
| Develop Health | Medication prior authorizations and specialty workflows | Pharmacy authorization coordinators Honey Health |
| Coral AI | Intake-heavy authorization workflows | Document processing staff Honey Health |
| LucasAI | Builds documentation while clinicians chart to reduce downstream PA work | Documentation preparation rather than full PA replacement LucasHealth |
These focus on utilization management rather than provider operations.
Typical capabilities include:
The newest AI-native systems generally automate much more than traditional RPA. A mature workflow can include:
This differs from older ePA vendors, which primarily route transactions and still rely on staff to manage exceptions.
If your definition is "could replace an operations team member rather than assist one," the strongest examples today are:
These position themselves as autonomous or agentic systems that execute work across existing EHRs and payer portals, rather than requiring users to operate another workflow application.
When evaluating these vendors, organizations typically look beyond automation claims and assess:
In practice, the leaders differ by setting: Mandolin and SamaCare are especially strong for specialty drugs and infusion workflows, while platforms such as Honey Health, Ascertain, and GenHealth target broader provider-side prior authorization across multiple service types.
Several AI-native and AI-powered platforms have emerged to shoulder or fully automate prior authorization (PA) workflows, reducing the need for heavy manual operations teams . These services address different sides of the ecosystem—some target provider-side submission and chart extraction, while others handle payer-side clinical reviews and decision support.
Prominent AI-driven platforms taking over these workflows include:
Are you looking to implement these tools on the provider side (to streamline clinic submissions and reduce rejections) or on the payer side (to automate utilization management and clinical reviews)? If you share your specific workflow bottlenecks, I can help narrow down the ideal platform fit.
Yes. If by “take over” you mean replace most of a human PA operations team rather than merely give staff a better work queue, the market is increasingly credible—but the vendors attack different parts of the workflow.
| Vendor | What it can automate | How close to “human team replacement”? | Best fit |
|---|---|---|---|
| waystar.com | Determine whether auth is required, gather clinical/order data, submit auths, check status, automate certain approvals, manage exceptions | High for transactional PA work | Hospitals, health systems, large provider groups |
| infinitus.ai | AI voice agents call payers/PBMs, navigate phone trees, obtain benefits/auth status and follow up | High for the phone-heavy portion humans still perform | Specialty care, ASCs, labs, specialty pharmacy |
| coherehealth.com | Clinical-information extraction, medical-necessity review, PA workflow, real-time decisions | Very high, but primarily on the payer/UM side | Health plans and organizations operating utilization management |
| rhyme.care | Provider-side PA connectivity, electronic submission and payer workflow | Medium–high | Organizations wanting API/EHR-centric PA automation |
| infinx.com | Eligibility, authorization, RCM automation, documentation/workflow support | Medium–high | Outsourced/enterprise RCM operations |
| surescripts.com | Electronic prescription PA, clinical information exchange and medication-related PA | High within pharmacy PA | Prescribing organizations / health systems |
The important distinction is that Waystar + Infinitus is closer to an “AI PA operations team” than any single product. Waystar handles the electronic/transactional layer, while Infinitus handles the cases where the payer still requires a phone conversation. Waystar says its Authorization Manager covers 30+ service lines and 70M annual authorization transactions, with exception-based worklists and automated status retrieval. Waystar Waystar Infinitus specifically automates payer calls and PA follow-up using voice agents.
coherehealth.com is particularly interesting if you're asking about replacing utilization-management operations, rather than merely replacing the provider's authorization coordinators.
Its platform performs clinical-information extraction and medical-necessity decisioning, and Cohere currently advertises 85% of prior authorizations approved in real time. It explicitly says its AI handles administrative work while humans retain control of critical clinical decisions.
So I'd characterize the landscape this way:
The key question isn't “Does it have AI?” It's:
What percentage of PA cases can go from order → auth determination → documentation assembly → submission → payer interaction → status → approval without a human touching it? I'd score vendors on six automation stages:
Most vendors are strong on 1–4. #5 is where Infinitus is unusually differentiated, while #6 is still where human operations teams tend to survive.
Waystar is explicitly moving toward agentic AI that executes revenue-cycle tasks with minimal intervention, including PA support.
Bottom line: If you're building a shortlist for a provider organization trying to replace a 10–100 person PA operations team, I'd start with Waystar, Infinitus, Rhyme, and Infinx. If you're a health plan, I'd put Cohere at the top of the list instead. The most interesting architecture may be Waystar (electronic rails) + Infinitus (voice/exception rails) + an agentic clinical/document layer, rather than betting on one monolithic vendor.
If you tell me provider vs. payer, specialty, approximate PA volume, and whether you want to eliminate FTEs or just reduce workload, I can narrow this to the 3–5 vendors most likely to actually replace the operation.
Several AI-native and agentic platforms are designed to take over repetitive prior authorization (PA) workflows from human operations teams . Rather than acting merely as electronic submission forms or basic fax routers, these services use large language models (LLMs) and intelligent agents to extract unstructured clinical evidence from EHRs, match it against complex payer policies, submit via APIs or browser/voice automation, and track statuses end-to-end.
The leading AI-native and deeply automated platforms addressing this space include:
Note on Industry Operations: While these tools significantly deflect human workloads (often achieving 80% to 90%+ touchless or real-time processing for routine cases), complete end-to-end replacement of human teams remains nuanced. Regulatory requirements—such as state-level restrictions on pure-AI medical necessity denials and complex peer-to-peer appeals—still mean that edge cases and subjective denials are typically routed back to human clinicians or operations specialists.
If you'd like, let me know:
I can help narrow down which platform fits your specific operational volume and tech stack.
Several AI-native platforms and intelligent automation services can handle or significantly reduce human operations workloads in healthcare prior authorization (PA). These tools use optical character recognition (OCR), large language models (LLMs), and FHIR/API integrations to extract clinical facts, match them to specific payer rules, pre-populate forms, and track requests.
While fully autonomous, "straight-through" processing is increasingly common for routine policy-aligned requests, most services maintain a human-in-the-loop governance model for complex clinical edge cases.
Leading AI-Driven Prior Authorization Services
If you'd like to narrow down these options, please share:
If the goal is to replace a human prior authorization operations team, the relevant category is not just “AI documentation tools.” You need AI agents that can execute the PA lifecycle: identify whether authorization is required, gather clinical evidence, complete payer forms, submit through portals/APIs/fax, monitor status, respond to requests, escalate exceptions, and document outcomes.
The market is splitting into a few architectures:
| Workflow owner | AI-native services | What they can take over |
|---|---|---|
| Provider / health system PA team | AI PA agents | Submission, follow-up, portal work, status chasing, documentation assembly |
| Health plan utilization management team | AI clinical decision engines | Intake, medical necessity review support, approvals/denials, correspondence |
| Pharma patient access / hub teams | AI access agents | Benefits verification, PA, appeals, payer calls, patient assistance workflows |
| RCM operations teams | AI revenue-cycle platforms | PA plus eligibility, denials, referrals, claims workflows |
Best fit: ambulatory groups, MSOs, specialty practices that want an “AI employee” handling PA work.
Capabilities:
It is positioned as an end-to-end provider-side PA agent rather than a simple rules engine.
Best fit: payers and utilization management organizations.
Capabilities:
Cohere focuses more on the payer decision side than replacing provider PA coordinators.
Best fit: health systems wanting PA automation inside broader revenue-cycle operations.
Capabilities:
(Compared with newer agentic vendors, Waystar is more of an established RCM platform expanding automation.)
These companies focus on the hardest PA categories: biologics, oncology drugs, infusion therapies, and specialty pharmacy.
Best fit: payer calls and access workflows.
Capabilities:
Best fit: specialty-drug hub workflows.
Capabilities:
For a payer trying to shrink a nurse reviewer or UM operations team:
Best fit: large payers that want orchestration across legacy systems.
Capabilities:
UiPath’s approach is usually to automate the workflow around clinicians rather than eliminate clinical judgment.
A realistic target operating model in 2026 is:
AI handles
Humans handle
Large health system / MSO
Specialty clinic (oncology, rheumatology, dermatology, infusion)
Health plan
The key diligence question is: does the vendor merely draft PA paperwork, or does it actually operate the workflow (submit, monitor, chase, and close the loop)? The latter category is what can materially reduce a human operations team.
Yes. The market has moved beyond “AI that helps a coordinator fill out a PA form” toward agentic systems that can own substantial portions of the workflow. But the vendors differ dramatically in how much of the human ops team they can actually replace.
| Vendor | What it can take over | Best fit | How autonomous? |
|---|---|---|---|
| Silna Health | Intake, payer-specific requirements, form generation, submission, tracking, follow-ups, expiration management, escalation | Provider groups / specialty practices | Closest to an end-to-end PA operations replacement |
| Infinitus | Payer phone calls, PA requirements/status, follow-up, appeals-related calls | High-volume workflows involving payer phone calls | Highly autonomous for the voice/call layer |
| Waystar | Determine whether PA is required, initiate authorization, gather/attach documentation, submit and track | Hospitals / health systems / enterprise RCM | High automation, but more platform/workflow than AI-agent replacement |
| Cohere Health | Clinical/document analysis and authorization decisioning, particularly on the payer side | Health plans / utilization management | Very high for payer-side PA; not primarily a provider ops replacement |
| SuperDial | PA requirements/status calls and other payer/provider calls | RCM teams with lots of phone work | High for repetitive communications |
Silna explicitly positions its product as managing the entire prior-auth process: monitoring expirations, identifying payer-specific documentation requirements, generating/submitting forms, following up, communicating approvals, and surfacing escalations.
That makes it interesting if the objective is:
“Give us the PA queue and let the software run it, rather than giving our coordinators another tool.”
Its remaining human work appears to be primarily exceptions—additional-information requests, unusual cases, resubmissions, and denials.
Infinitus is particularly interesting because it doesn't stop at electronic PA.
Its agents actually call payers, navigate the conversation, ask for requirements/status, and return the information to the provider's system. Infinitus says its PA agents cover specialty drugs, procedures and diagnostics and have expertise across 1,000+ therapies.
That's important because a PA “workflow” often looks like:
EHR → payer portal → fax → payer phone call → hold → transfer → missing document → another call → status check → resubmission
Infinitus can automate that telephone layer rather than forcing humans to remain the integration glue.
Waystar has a much broader installed-base strategy. Its Authorization Manager uses AI/automation to determine whether authorization is required, initiate authorizations, analyze EHR/HIS/PM orders, attach clinical documentation and automate certain submissions and notifications.
I'd categorize it as “AI-enabled PA infrastructure” rather than a pure AI-native workforce replacement.
That's potentially a feature rather than a bug for a health system: it is more likely to fit into existing RCM infrastructure.
Cohere Health is much more oriented toward the payer/UM side.
Its AI analyzes structured and unstructured clinical records against payer policies and says its automation handles the majority of PA decisions, with 85% of authorizations approved in real time depending on specialty.
So if by “take over PA” you mean replace the payer's utilization-management operation, Cohere is arguably one of the strongest companies in the category.
If you mean replace the provider's 10-person PA department, it's not the same product.
SuperDial offers agents for insurance verification, PA requirements/status, claims follow-up, credentialing and other payer/provider calls.
I'd view it as particularly compelling when your PA operation is already fairly good electronically but burns enormous amounts of labor on calling insurance companies.
This is the distinction I'd use when evaluating the market.
Tier 1 — Copilot
“Here's the PA form and the clinical evidence you should attach.”
Doesn't replace many people.
Tier 2 — Workflow automation
“I'll determine whether PA is required, assemble the packet, submit it and track the status.”
Can substantially reduce headcount.
Tier 3 — Agentic PA operations
“Give me the order. I'll figure out the payer requirements, obtain missing information, assemble the clinical packet, submit it through whatever channel is necessary, call the payer when required, monitor the authorization, respond to routine requests, update the EHR and escalate only exceptions.”
This is the category that can actually replace an operations team.
Silna + Infinitus are particularly interesting when viewed through that lens: one is closer to owning the workflow, while the other is exceptionally strong at the payer-communication layer.
There is a meaningful gap between vendor demos and completely unattended healthcare administration. Two 2026 benchmarks are especially revealing: HealthAdminBench found the best computer-use agent achieved only 36.3% end-to-end task success across realistic healthcare-admin tasks, while CHI-Bench found the best configuration resolved only 28% of its long-horizon healthcare workflows.
That suggests the realistic 2026 architecture is:
AI handles 70–95% of routine cases → humans handle an exception queue, rather than “fire the entire PA department.”
And that's actually the business model I'd want to buy. The vendor should be willing to contract around touchless authorization rate, exception rate, turnaround time, and accuracy, not merely “AI-assisted productivity.”
If I were evaluating this for a provider organization today, I'd put the first calls into:
The key diligence question for each isn't “How much does your AI automate?” It's:
“If I give you 10,000 PA cases tomorrow, exactly which steps happen without a human touching them, which steps require a human, and can you show me the touchless rate by payer and specialty?”
That's the metric that separates a genuine AI-native replacement for a PA ops team from another RCM productivity tool.
AI-native platforms are shifting prior authorization (PA) from a manual, human-heavy operational hurdle to an automated, "straight-through processing" workflow . These services use large language models (LLMs), natural language processing (NLP), and specialized AI agents to extract clinical facts from electronic health records (EHRs), map them against complex payer rules, submit the paperwork, and track statuses.
The leading AI-native and AI-enhanced services capable of substantially taking over these workflows from human operations teams include:
If you are evaluating these for a specific setting, would you like to share whether you are looking from the provider side (hospitals/clinics) or the payer side (insurance/PBM) , and what EHR system you need to integrate with?